recently conducted a multiplexed sequencing on 242 glioma tumors for mutations of IDH1/2, H3F3A, HIST1H3B, and TERT genes concomitantly to RAS isotypes [150]. This evidence concerns the gene IDH1 and central nervous system cancer.